Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 48INDUSTRY 24NIH 9NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 37Sarcoma 14Lymphoid 3Thoracic 2Gastrointestinal 2Endocrine 2Dermatologic 2Other hematologic neoplasm 1

Conditions

Melanoma 2Neoplasm Metastasis 1Brain Neoplasms 1

Interventions

Interferon-alpha 6Radiosurgery 4Dacarbazine 4encorafenib 3binimetinib 3aldesleukin 3Radiotherapy 3Methotrexate 3Immunohistochemistry 3Gene Expression Profiling 3Filgrastim 3Etoposide 3Cyclophosphamide 3Cisplatin 3Watchful Waiting 2Vincristine 2Vinblastine 2Temozolomide 2Polymerase Chain Reaction 2Nivolumab 2Ipilimumab 2Introns 2Interferon alpha-2 2Immunologic Techniques 2Flow Cytometry 2Carboplatin 2trametinib 1tebentafusp 1sulforaphane 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Temozolomide × Dermatologic × Clear all
NCT00020839 2012-09-24

Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
23 enrolled
CNSDermatologic

Brain Neoplasms, Melanoma, Neoplasm Metastasis

NCT00104988 2012-08-22

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

SWOG Cancer Research Network

Phase 2 Completed
64 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡